Innovation Newsroom

Dec 22, 2020

Royal Philips , a global leader in health technology, and BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.

Dec 17, 2020

Aurora, Colo., Dec. 17, 2020 (GLOBE NEWSWIRE) -- As UCHealth begins administering the Pfizer COVID-19 vaccine to health care workers today at University of Colorado Hospital on the University of Colorado Anschutz Medical Campus, some recipients will be wearing the BioIntelliSense BioButton medical device as a foundational step in developing a scalable post-vaccine monitoring program that could be deployed more broadly in high-risk patient populations.

Dec 11, 2020

Universities across the country are celebrating today the 40th anniversary of the Patent and Trademark Amendments Act of 1980, better known as the “Bayh-Dole Act” after its sponsors. The Bayh-Dole was historic because it created a uniform federal intellectual property policy for inventions created at universities and other federally-funded institutions. This allows universities to own the intellectual property covering their research, which enables them to develop and commercialize their discoveries in order to bring them to the public.